THE EFFECT OF 2 SYNTHETIC PHOSPHOLIPIDS ON CELL-PROLIFERATION AND PHOSPHATIDYLCHOLINE BIOSYNTHESIS IN MADIN-DARBY CANINE KIDNEY-CELLS

被引:41
作者
WIEDER, T
HAASE, A
GEILEN, CC
ORFANOS, CE
机构
[1] Haut- und Poliklinik, Universitätsklinikum Benjamin Franklin, Berlin, 12200, Freie Universität Berlin
关键词
D O I
10.1007/BF02536296
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The concentration-dependent effects of two different synthetic phospholipids on cell proliferation and phosphatidylcholine biosynthesis were compared in Madin-Darby canine kidney (MDCK) cells. The alkyllysophospholipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine and the alkylphosphocholine, hexadecylphosphocholine, inhibited cell proliferation with half-inhibitory concentrations (IC50) of 75 and 135 mu mol/L, respectively. The agents also inhibited phosphatidylcholine biosynthesis in confluent and proliferating MDCK cells. The IC50 of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine was 40 mu mol/L in confluent cells and 20 mu mol/L in proliferating cells, whereas the IC50 of hexadecylphosphocholine was higher in both experimental systems (67 mu mol/L in confluent cells and 40 mu mol/L in proliferating cells). Further experiments revealed that the effect of both agents on phosphatidylcholine biosynthesis was reversible and that the inhibition was mediated by translocation of the rate-limiting enzyme of this pathway, CTP:phosphocholine cytidylyltransferase (EC 2.7.7.15), from membranes to the cytosol, where it is inactive. The present findings suggest that the inhibition of phosphatidylcholine biosynthesis by both synthetic phospholipids might be related, in part, to their antiproliferative effects.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 31 条
[1]  
Berdel W.E., Andreesen R., Munder P.G., Phospholipids and Cellular Regulation, pp. 41-77, (1985)
[2]  
Kosano H., Takatani O., Cancer Res., 48, pp. 6033-6036, (1988)
[3]  
Modolell M., Andreesen R., Pahlke W., Brugger U., Munder P.G., Cancer Res., 39, pp. 4681-4686, (1979)
[4]  
Herrmann D.B.J., Neumann M.A., J. Biol. Chem., 261, pp. 7742-7747, (1986)
[5]  
Lu X., Arthur G., Cancer Res., 52, pp. 2806-2812, (1992)
[6]  
Lu X., Arthur G., Cancer Res., 52, pp. 2813-2817, (1992)
[7]  
Unger C., Eibl H., Breiser A., von Heyden H.W., Engel J., Hilgard P., Sindermann H., Peukert M., Nagel G.A., Onkologie, 11, pp. 295-296, (1988)
[8]  
Wieder T., Geilen C.C., Reutter W., Biochem. J., 291, pp. 561-567, (1993)
[9]  
Geilen C.C., Haase A., Wieder T., Arndt D., Zeisig R., Reutter W., J. Lipid Res., 35, pp. 625-632, (1994)
[10]  
Geilen C.C., Haase R., Buchner K., Wieder T., Hucho F., Reutter W., Eur. J. Cancer, 27, pp. 1650-1653, (1991)